Anavex Life Sciences Corp (AVXL)

[orveko_inc]

The patent provides IP protection until at least 2035

That is what the PR stated, but I'm still not sure about that. Patent 9,180,106 was granted from application 14/205637 (filing date: 3/12/2014), which was a continuation of application 13/201271 (filing date: 8/12/2011).

Per the USPTO:

A patent granted on a continuation, divisional, or continuation-in-part application that was filed on or after June 8, 1995, will have a term which ends twenty years from the filing date of earliest application for which a benefit is claimed under 35 U.S.C. 120, 121, 365(c), or 386(c) regardless of whether the application for which a benefit is claimed under 35 U.S.C. 120, 121, or 365(c) was filed prior to June 8, 1995.

The Patent Term Adjustment (time that can extend the term beyond 20 years) was "0 days" for this patent.